Amneal Receives FDA Approval for Generic Albuterol Sulfate Inhalation Aerosol
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has announced that the U.S. Food and Drug Administration (FDA) has approved its albuterol …
Pharma News
Admissions Open: Biocon KGI Certificate Program in Biosciences – Batch 31
Elevate your biotech career with the Biocon KGI Certificate Program in Biosciences. Admissions now open for …
Biocon Announces Leadership Transition – Shreehas Tambe to Lead the Combined Biocon and Biocon Biologics Business
Bengaluru, India — December 8, 2025: Biocon Limited announced that its subsidiary, Biocon Biologics, will become a …
Sudeep Pharma IPO: Shares List at 23% Premium, Close 30% Higher on Debut; Market Cap Tops ₹8,100 Crore
Sudeep Pharma’s strong listing saw its shares close over 30% above the IPO price on debut, …
Calling All Chemistry, Biochemistry, and Pharmacy Students – Unlock Drug Action Mechanisms in Biocon Academy’s Exclusive Webinar
Dive into the fascinating world of pharmacology with Biocon Academy’s free webinar on drug action, safety, …
Biocon Academy – Certificate Program in Global Regulatory Affairs (Batch 5) | Admissions Open 2025
Admissions open for Biocon-JSS AHER Certificate Program in Global Regulatory Affairs Batch 5! Premier industry-oriented program …
Unlock Systems Biology Expertise: RCB-UCSD Certificate Course on Data Analysis for Systems Biology
Elevate your biotech career with cutting-edge systems biology training! Join the RCB-UCSD hybrid course on genomics, …
Ind-Swift Laboratories Issues Unprecedented “Apology” for Unmatched Service Excellence
Ind-Swift Laboratories Limited, a renowned name in global pharmaceutical manufacturing and supply, has made headlines with …
Aurobindo Pharma’s API Facility Receives EIR from USFDA
Aurobindo Pharma Limited announced that its wholly owned subsidiary, Apitoria Pharma Private Limited, has received an Establishment Inspection …
Natco Pharma Acquires 35.75% Stake in Adcock Ingram for USD 226 Million, Expands Global Footprint in South Africa
Natco Pharma Limited has completed the acquisition of a 35.75% stake in Adcock Ingram Holdings Limited, …